CN1249224C - 超氧化物歧化酶组合物及其制备方法 - Google Patents
超氧化物歧化酶组合物及其制备方法 Download PDFInfo
- Publication number
- CN1249224C CN1249224C CN 200510008719 CN200510008719A CN1249224C CN 1249224 C CN1249224 C CN 1249224C CN 200510008719 CN200510008719 CN 200510008719 CN 200510008719 A CN200510008719 A CN 200510008719A CN 1249224 C CN1249224 C CN 1249224C
- Authority
- CN
- China
- Prior art keywords
- superoxide
- dismutase
- composition
- add
- precipitation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 title claims abstract description 77
- 108010012715 Superoxide dismutase Proteins 0.000 title claims abstract description 77
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 40
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 20
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 20
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 20
- 239000011718 vitamin C Substances 0.000 claims abstract description 20
- 229940046009 vitamin E Drugs 0.000 claims abstract description 20
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 20
- 239000011709 vitamin E Substances 0.000 claims abstract description 20
- 210000004369 blood Anatomy 0.000 claims abstract description 18
- 239000008280 blood Substances 0.000 claims abstract description 18
- 238000000034 method Methods 0.000 claims abstract description 18
- 241001465754 Metazoa Species 0.000 claims abstract description 17
- 239000002202 Polyethylene glycol Substances 0.000 claims abstract description 10
- 229920001223 polyethylene glycol Polymers 0.000 claims abstract description 10
- 229940032362 superoxide dismutase Drugs 0.000 claims description 63
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 58
- 238000001556 precipitation Methods 0.000 claims description 35
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 30
- 239000006228 supernatant Substances 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 26
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 24
- 241000241413 Propolis Species 0.000 claims description 24
- 229940069949 propolis Drugs 0.000 claims description 24
- 238000004108 freeze drying Methods 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 20
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 19
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 18
- 238000005119 centrifugation Methods 0.000 claims description 16
- 235000016425 Arthrospira platensis Nutrition 0.000 claims description 15
- 240000002900 Arthrospira platensis Species 0.000 claims description 15
- 229940082787 spirulina Drugs 0.000 claims description 15
- 238000005303 weighing Methods 0.000 claims description 14
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 12
- 239000008367 deionised water Substances 0.000 claims description 12
- 229910021641 deionized water Inorganic materials 0.000 claims description 12
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims description 12
- -1 polyoxyethylene Polymers 0.000 claims description 12
- 206010018910 Haemolysis Diseases 0.000 claims description 11
- 230000008588 hemolysis Effects 0.000 claims description 11
- 239000008057 potassium phosphate buffer Substances 0.000 claims description 11
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 239000012153 distilled water Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 8
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 claims description 7
- 230000010100 anticoagulation Effects 0.000 claims description 6
- CVOQYKPWIVSMDC-UHFFFAOYSA-L dipotassium;butanedioate Chemical compound [K+].[K+].[O-]C(=O)CCC([O-])=O CVOQYKPWIVSMDC-UHFFFAOYSA-L 0.000 claims description 6
- 239000002244 precipitate Substances 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 239000013049 sediment Substances 0.000 claims description 5
- UXTMROKLAAOEQO-UHFFFAOYSA-N chloroform;ethanol Chemical compound CCO.ClC(Cl)Cl UXTMROKLAAOEQO-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 239000012043 crude product Substances 0.000 claims description 4
- 210000003743 erythrocyte Anatomy 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000013467 fragmentation Methods 0.000 claims description 4
- 238000006062 fragmentation reaction Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 102000004169 proteins and genes Human genes 0.000 claims description 4
- 230000001954 sterilising effect Effects 0.000 claims description 4
- 238000004659 sterilization and disinfection Methods 0.000 claims description 4
- 230000004913 activation Effects 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000002504 physiological saline solution Substances 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 230000002785 anti-thrombosis Effects 0.000 claims description 2
- 229960004676 antithrombotic agent Drugs 0.000 claims description 2
- 239000012141 concentrate Substances 0.000 claims description 2
- 238000010612 desalination reaction Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000001509 sodium citrate Substances 0.000 claims description 2
- GNFTZDOKVXKIBK-UHFFFAOYSA-N 3-(2-methoxyethoxy)benzohydrazide Chemical compound COCCOC1=CC=CC(C(=O)NN)=C1 GNFTZDOKVXKIBK-UHFFFAOYSA-N 0.000 claims 2
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 2
- 238000013270 controlled release Methods 0.000 claims 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 4
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 2
- 235000012000 cholesterol Nutrition 0.000 abstract description 2
- 201000010099 disease Diseases 0.000 abstract description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 abstract 2
- 241000283690 Bos taurus Species 0.000 abstract 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 abstract 1
- 208000031481 Pathologic Constriction Diseases 0.000 abstract 1
- 229930003268 Vitamin C Natural products 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 230000036737 immune function Effects 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 208000037804 stenosis Diseases 0.000 abstract 1
- 230000036262 stenosis Effects 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 description 23
- 241000699666 Mus <mouse, genus> Species 0.000 description 17
- 230000009182 swimming Effects 0.000 description 13
- 238000000703 high-speed centrifugation Methods 0.000 description 11
- 230000037396 body weight Effects 0.000 description 10
- 238000002474 experimental method Methods 0.000 description 9
- 239000000047 product Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 210000002784 stomach Anatomy 0.000 description 5
- 241000255601 Drosophila melanogaster Species 0.000 description 4
- 239000012488 sample solution Substances 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000002929 anti-fatigue Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000003203 everyday effect Effects 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000005847 immunogenicity Effects 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 2
- 241000699670 Mus sp. Species 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000004459 forage Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002035 prolonged effect Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 1
- 241000288673 Chiroptera Species 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 206010036030 Polyarthritis Diseases 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000382353 Pupa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 230000003516 hyperlipidaemic effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
饲料中实施例3组合物浓度(%) | 性别 | 样本数 | 半数死亡时间(天) |
00.0130.0400.1200.360 | ♀♂♀♂♀♂♀♂♀♂ | 200200200200200200200200200200 | 61586463646160626061 |
饲料中实施例3组合物浓度(%) | 性别 | 样本数 | 平均寿命(d) | P值 | 最高寿命 | P值 |
00.0130.0400.1200.360 | ♀♂♀♂♀♂♀♂♀♂ | 200200200200200200200200200200 | 58.7±13.354.9±12.459.6±13.658.7±12.1**60.8±14.056.4±13.956.9±13.858.2±12.7**57.7±14.156.1±12.3 | --0.51830.00160.13160.25430.18330.00820.45050.3030 | 76.5±2.773.9±3.978.6±3.5*76.2±2.6*80.1±2.7***77.7±3.1**77.6±3.177.7±1.9***76.1±3.174.4±3.5 | --0.04190.03600.00010.00150.21620.00040.66820.6744 |
组别 | 剂量(g/kg.bw) | 分组时体重(g)1,2 | 游泳前体重(g)1,3 |
正常对照组低剂量组中剂量组高剂量组 | -0.040.200.60 | 19.2±0.9(15)19.6±1.0(15)19.3±0.6(15)19.2±0.7(15) | 40.5±1.6(15)38.3±2.1(15)39.6±2.9(15)38.6±2.8(15) |
组别 | 剂量(g/kg.bw) | 动物数(只) | 游泳时间(min)1,2 |
正常对照组低剂量组中剂量组高剂量组 | -0.040.200.60 | 15151515 | 19.1±19.232.2±34.3)38.5±36.657.1±41.2* |
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510008719 CN1249224C (zh) | 2005-02-24 | 2005-02-24 | 超氧化物歧化酶组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200510008719 CN1249224C (zh) | 2005-02-24 | 2005-02-24 | 超氧化物歧化酶组合物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1654640A CN1654640A (zh) | 2005-08-17 |
CN1249224C true CN1249224C (zh) | 2006-04-05 |
Family
ID=34894138
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200510008719 Active CN1249224C (zh) | 2005-02-24 | 2005-02-24 | 超氧化物歧化酶组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1249224C (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100360666C (zh) * | 2005-11-29 | 2008-01-09 | 沈阳农业大学 | 一种修饰玉米sod的方法 |
CN106754691A (zh) * | 2016-12-12 | 2017-05-31 | 扬州大学 | 一种从家禽全血样本快速分离高纯度红细胞的方法 |
-
2005
- 2005-02-24 CN CN 200510008719 patent/CN1249224C/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN1654640A (zh) | 2005-08-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104349784A (zh) | 动物饲料组合物及使用其的方法 | |
CN1891240A (zh) | 一种含多种灵芝活性成分的中药组合物及其制备方法 | |
CN1875996A (zh) | 一种具有抗氧化作用的组合物 | |
CN1457808A (zh) | 一种铁皮石斛复方制剂及制备和应用 | |
CN1384750A (zh) | 植物提取物混合物及其用途 | |
CN112057546A (zh) | 一种蜂胶灵芝孢子粉组合物及其制备方法和应用 | |
CN1249224C (zh) | 超氧化物歧化酶组合物及其制备方法 | |
CN1204238C (zh) | 从核桃仁中提取的核桃仁油组合物及其药物制剂 | |
CN1957956A (zh) | 一种具抗肿瘤和免疫调节作用的多菌组合物及其制备方法与用途 | |
CN1915986A (zh) | 一种高纯度的丹参酮iia磺酸钠、制备方法及其制剂 | |
CN1202067C (zh) | 药用级枸橼酸铁的制备方法 | |
CN1901927A (zh) | α-葡萄糖苷酶活性抑制剂 | |
CN1400298A (zh) | 从植物果仁中提取的果仁油,其提取方法、药物组合物及应用 | |
CN1663606A (zh) | 一种治疗放射病的药物 | |
CN1377702A (zh) | 灵芝破壁孢子粉胶囊 | |
CN1107501C (zh) | 阿苯达唑乳剂 | |
CN1175899C (zh) | 一种药物组合物及其制备方法和用途 | |
CN1150917C (zh) | 大花红景天有效成份制剂及制备方法 | |
CN1034860A (zh) | 小球藻提取物及其应用 | |
CN1634555A (zh) | 一种治疗慢性胃炎的药物 | |
CN1278676C (zh) | 姜黄素注射制剂及其制备方法 | |
CN1173640C (zh) | 一种保健营养品 | |
CN1299684C (zh) | 水产动物抗菌药及其制备方法 | |
CN1421238A (zh) | 一种具有抗肿瘤、抗自由基损伤和调节免疫的天然生物反应调节剂 | |
CN1355022A (zh) | 枸杞多糖在制备治疗脂肪肝药物中的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1077844 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20181022 Address after: 136200 seventeen group of three Committee of Dongji street, Longshan District, Liaoyuan, Jilin Patentee after: Sun Yinghao Address before: 136200 four Hun Road 12, Liaoyuan, Jilin Patentee before: Sun Longxiang |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220114 Address after: 136200 room 210, building 32, Xinghe Wanyuan happiness Park, 1126 Binhe South Road, Longshan District, Liaoyuan City, Jilin Province Patentee after: Jilin Tianyi Biotechnology Co.,Ltd. Address before: 136200 seventeen group of three Committee of Dongji street, Longshan District, Liaoyuan, Jilin Patentee before: Sun Yinghao |
|
TR01 | Transfer of patent right |